Organisation paid for research Program year 2024 Source: CMS Open Payments

US Dermatology Partners Phoenix

Neither a doctor nor a teaching hospital

Research payments

$52,080

4 payments

Through program year 2024, US Dermatology Partners Phoenix is reported as receiving $52,080 in research payments, across 4 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$44,266	2
2023	Research	$7,815	2

Breakdown

Who paid Research payments · program years 2023–2024

E.R. Squibb & Sons, L.L.C. $31,490 2 payments
AstraZeneca UK Limited $20,590 2 payments

Studies the money was for Research payments · program years 2023–2024

A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUTING IMPACT OF DEUCRAVACITINIB ON QoL, EFFICACY AND SAFETY IN PATIENTS WITH PLAQUE PSORIASIS AND IMPAIRED HEALTH-RELATED QUALITY OF LIFE $31,490 2 payments
A multicenter randomized double-blind parallel group placebo controlled study to Investigate the use of Benralizumab as a treatment option for patients with moderate to severe Bullous Pemphigoid $20,590 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.